Use of anti-thymocyte globulin (ATG) for the treatment of pure red cell aplasia and immune-mediated cytopenias after allogeneic hematopoietic cell transplantation: a case series. Article uri icon

Overview

publication date

  • May 18, 2020

Research

keywords

  • Graft vs Host Disease
  • Hematopoietic Stem Cell Transplantation
  • Red-Cell Aplasia, Pure

Identity

Scopus Document Identifier

  • 85085028479

Digital Object Identifier (DOI)

  • 10.1038/s41409-020-0939-9

PubMed ID

  • 32424188

Additional Document Info

volume

  • 55

issue

  • 12